At Abbott, we're committed to helping people live their best possible life through the power of health. For more than 130 years, we've brought new products and technologies to the world -- in nutrition, diagnostics, medical devices and branded generic pharmaceuticals -- that create more possibilities for more people at all stages of life. Today, 99,000 of us are working to help people live not just longer, but better, in the more than 150 countries we serve.
For decades, the Ecclesia Group has been the reliable partner for hospitals in matters of risk protection. The strength and concentration necessary to incorporate new developments into care systems and to successfully translate them into insurance concepts, which are supported by the insurance industry, have helped Ecclesia to ascend to market leadership in Germany and to become a significant player in Europe.
Since 1994, the Ecclesia group company GRB – Gesellschaft für Risiko-Beratung mbH – has been supporting hospitals in Germany and Europe in developing and implementing risk management systems.Ecclesia maintains Europe’s largest database for medical malpractice claims with more than 13,000 new claims per year. These claims are analyzed and the results are used as a basis for study and are assimilated into new concepts. In so doing, the Group, as a specialist service provider for the healthcare sector, reflects findings relevant to loss prevention and patient safety back into the system.
The Ecclesia Group is partner of the German Association of Hospital Managers (VKD) at national level and of the European Association of Hospital Managers (EAHM) at European level. Companies and associations equally profit from the intense exchange aiming at continuously improving the safety culture in hospitals for the benefit of patients.
Facts and Figures
- Initially founded in 1909, corporate form as GmbH (limited liability company)since 1952
- Headquartered in Detmold (North Rhine-Westphalia)
- 1,550 employees
- Annual turnover of 204 million Euros
- Providing advice and assistance to 1,362 hospitals in Germany
- Market share in the hospital segment (Germany) of about 70 percent
- Leading in providing support to hospitals in Austria
- Own companies in Austria, Switzerland, Italy, Belgium, The Netherlands, Poland
- Global reach as a Partner of the JLT International Network, London
We are Janssen. We collaborate with the world for the health of everyone in it.
At Janssen, the pharmaceutical companies of Johnson & Johnson, our mission is to transform individual lives and change fundamentally the way diseases are managed, interpreted, and prevented.
The Johnson & Johnson Medical Devices Companies' purpose is to reach more patients and restore more lives. Having advanced patient care for more than a century, these companies represent an unparalleled breadth of products, services, programs, and research and development capabilities in surgical technology, orthopedics, cardiovascular, and specialty solutions with an offering directed at delivering clinical and economic value to healthcare systems worldwide.
To learn more, please visit us on: https://www.jnjmedicaldevices.com/en-EMEA
LG Electronics Portugal was founded in 2003 and has around 90 employees. The Business, which in 2007 reached 150 million euros in global sales, incorporates five business units - Home Entertainment, Home Appliances, Mobile Communications, Business Solutions and Air Conditioning. LG Electronics Portugal is, in our country, a distributor of Smartphones, Air Conditioning Systems, Home Cinema systems, Super UHD and OLED TV's, refrigerators - Bottom freezers and side-by-side, Washing Machines and Dishwashers, monitors, projectors, digital signage, hotel solutions, among others.
For more information: http://lg.com/pt
Tecnimede Group is composed by pharmaceutical companies of private and 100% Portuguese capital. Started its activity in 1980 and covers the entire life cycle of the medicinal products for human use — development, manufacture, promotion and marketing. Its strategy is based on strong investment in Research, Development, and Production of Medicinal Products.
It is intended that the results obtained allow to consolidate the Group's position in the Portuguese market and to strengthen exports and internationalisation. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants. Atlantic Pharma Brasil and Atlas Pharm (Morocco) are an example of the Group's expansion and development of manufacturing plants.
The Tecnimede Group was honoured in the Golden Company category at the 30th edition of the IRG Awards (Investor Relations & Governance Awards), a Deloitte initiative.
The IRG Awards aim to reward outstanding achievements from the previous year in the Portuguese financial and business market.
The Jury presented the Golden Company award this year to the Tecnimede Group based on its assessment that the company excels in the values of management and governance transparency and quality, made patent by the company’s size, performance, international presence and future potential.
Winners were selected by an extensive electoral college comprising representatives from entities operating in the financial and business market, and approved by a panel of judges led by Manuel Alves Monteiro. Other members of jury for this edition included Alberto de Castro, António Gomes Mota, António Saraiva, Esmeralda Dourado, João Duque, Jorge Coelho, Luís Amado, Patrícia Teixeira Lopes and Rui Rio.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.pfizer.com. In addition, to learn more, please visit us on www.pfizer.com and follow us on Twitter at @Pfizer and @PfizerNews, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
GLINTT is a leading player in healthcare services, offering consultancy and technology solutions to pharmacies, hospitals and other stakeholders of the healthcare value chain for more than 20 years. Nowadays, our solutions are used in more than 200 hospitals and clinics and more than 12.000 pharmacies in the Iberian Peninsula use our management software. Our vast knowledge about the market and the solid relationships we have built with our partners, based on reliability and mutual trust, allow us to understand what is relevant and to turn our knowledge into sustainable and valuable solutions.
GLINTT has been focused on fostering innovation and leverage technology to promote better healthcare at controlled costs. Actually, innovation is integral to GLINTT’s mission to “contribute with technological innovation to improve the levels of health and wellbeing in the global society we live on”.
GLINTT is uniquely positioned in the healthcare value chain, with access to delivery channels, proprietary software solutions and a network of experts, being supported by people with know-how and experience in healthcare and technology which bring the capacity for technological and scientific delivery and innovation.
Because of that, as partner for innovation, GLINTT can act across all stages of the innovation process bringing unique and differential assets at each step. Our people and network grant us with knowledge and access to key players in the health ecosystem and unique conditions to participate in innovation projects as mentor or consortium participant.
As a result of our focus on excellence, our significant investment in R&D, the many partnerships we have established with leading universities and our participation in several international consortiums, GLINTT is proudly owner of a remarkable intellectual property portfolio.
Linde Healthcare in homecare
Our services enable over 1.8 million people in more than 60 countries worldwide to receive therapy at home. We have always been known for our expertise in respiratory homecare, but our competencies cover the full spectrum of services and we always focus on patients’ individual needs. Clinical knowledge and extensive experience across multiple therapeutic areas enables us to support practitioners along every stage of the treatment process.
Working in close partnership with patients, caregivers, practitioners and payers, we help to ensure continuity and efficiency of care.
Micromil is a Portuguese company with more than 30 years of experience in the multi brand service delivery to the Medical Imaging area. Micromil provides an excellent service to all that use Imaging Healthcare, through technological advanced equipment and professional repairs that assure the reliability of results and the extension of the life cycle of the Imaging equipment.
Micromil is an ISO9001 certified company that sells and repairs imaging medical equipment, parts and accessories, of almost brands and models in the market, and provides highly specialized multi brand maintenance and technical service, as well as,consulting and planning of areas for imaging rooms,including technical training and installation and deinstallation of imaging equipment.
Takeda is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished over 230-year history, aspiring to bring better health and a brighter future for people worldwide. The network of Takeda spans over 70 countries and regions worldwide, in Japan, the United States, Europe, Latin America, Africa, the Middle East, and the Asia Pacific Region. Takeda's pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners).
Takeda Worldwide: https://www.takeda.com
Takeda Portugal: https://www.takeda.com/pt-pt